ReviewBioMed research international2021

CD80 Insights as Therapeutic Target in the Current and Future Treatment Options of Frequent-Relapse Minimal Change Disease.

Yoong Mond Teh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.